David Bautz
Latest Articles
A Closer Look At Tonix's Pending PTSD Data
BiondVax's Universal Influenza Vaccine Has Blockbuster Potential
Misunderstanding Surrounding BrainStorm Data Publication Presents Buying Opportunity
6 For '16: 6 Small-Cap Biotech Stocks With Important Catalysts In 2016
Ongoing Clinical Programs And Uplisting Possibility Make Protalex A Buy
Bellus Health Developing Shigamab For The Treatment Of STEC-HUS
An In-Depth Look At Pieris Pharmaceuticals Preclinical Data For PRS-343
New Technologies Under Development To Combat Antibiotic Resistant Organisms
Small-Cap Biotech Companies Looking To Find A Niche In The Rheumatoid Arthritis Market
Immune Pharmaceuticals Secures Long-Term Funding For Expanding Pipeline
An Overview Of Immune Pharmaceuticals As Bertilimumab Enters The Clinic
Enumeral Biomedical Is An Overlooked Player In Immuno-Oncology
Lipocine Continues To Generate Positive Data
Recent Study Results Show Broad Potential For GlassesOff App
Nuvo Research: An Overlooked Stock With Great Upside Potential
Preview: FDA September 17 Adcom On Testosterone Replacement Therapy
Lipocine Is A Compelling Investment Opportunity With Impending Phase 3 Data
Positive Clinical Results With Fortetropin Keep Us Bullish On MYOS Corp.
AmpliPhi Biosciences: Developer Of Antibacterial 'Smartbombs'